
Gayland Hethcoat II
Articles
-
Sep 4, 2024 |
jdsupra.com | Shoshana Golden |Douglas Grimm |Gayland Hethcoat II
In 2021, we provided an overview of multiple federal lawsuits challenging the US Department of Health and Human Services (HHS) Health Resources and Services Administration’s (HRSA) enforcement of the 340B Drug Pricing Program, particularly with respect to contract pharmacies. Three years later, the “340B Saga” continues. Following the filing of new cases and developments in others, we are back with another update.
-
Aug 22, 2024 |
jdsupra.com | Gayland Hethcoat II |Moyosore Koya
On June 20, a federal district court in Texas ruled that the US Department of Health and Human Services (HHS) Office for Civil Rights (OCR) exceeded its authority under the Health Insurance Portability and Accountability Act (HIPAA) by issuing guidance that expanded the law’s definition of “individually identifiable health information” (IIHI) to include an individual’s IP address captured on a public webpage about health conditions or health care providers.
-
Jun 19, 2024 |
jdsupra.com | Gayland Hethcoat II
Who will notify the potentially millions of individuals whose information might have been jeopardized by the massive cyberattack on Change Healthcare? Since the affiliate of UnitedHealth Group (UHG) first reported the cyberattack in February, health care providers have been uncertain about their notification responsibilities under the Health Insurance Portability and Accountability Act of 1996 (HIPAA).
-
May 29, 2024 |
jdsupra.com | Gayland Hethcoat II |Moyosore Koya |Jill Steinberg
On April 26, the US Department of Health and Human Services Office for Civil Rights (OCR) published a Final Rule that adds protections under the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule designed to support the privacy of reproductive health care.
-
May 15, 2024 |
jdsupra.com | Douglas Grimm |Gayland Hethcoat II |Stephanie Trunk
Disputes between 340B Drug Pricing Program-covered entities and the drug manufacturers required to sell outpatient drugs to those entities at discounted prices will be governed by an alternative dispute resolution (ADR) process under a Final Rule published on April 19, by the US Department of Health and Human Services’ Health Resources and Services Administration (HRSA).
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →